Targeting the Interplay of Independent Cellular Pathways and Immunity: A Challenge in Cancer Immunotherapy

被引:3
|
作者
Lauriola, Angela [1 ]
Davalli, Pierpaola [2 ]
Marverti, Gaetano [2 ]
Santi, Spartaco [3 ,4 ]
Caporali, Andrea [5 ]
D'Arca, Domenico [2 ]
机构
[1] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy
[2] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Via G Campi 287, I-41125 Modena, Italy
[3] CNR, Inst Mol Genet Luigi Luca Cavalli Sforza, I-40136 Bologna, Italy
[4] IRCCS, Ist Ortoped Rizzoli, I-40136 Bologna, Italy
[5] Univ Edinburgh, BHF Ctr Cardiovasc Sci, Edinburgh EH4 2XU, Scotland
关键词
immunotherapy; cancer; immunotherapy-challenges; immunotherapy-limitations; PROSTATE-CANCER; PHASE-II; NAB-PACLITAXEL; PATIENTS PTS; OPEN-LABEL; T-CELLS; TUMOR MICROENVIRONMENT; RECURRENT GLIOBLASTOMA; PLUS CHEMOTHERAPY; BEVACIZUMAB BEV;
D O I
10.3390/cancers15113009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immunotherapy is a cancer treatment that exploits the capacity of the body's immune system to prevent, control, and remove cancer. Immunotherapy has revolutionized cancer treatment and significantly improved patient outcomes for several tumor types. However, most patients have not benefited from such therapies yet. Within the field of cancer immunotherapy, an expansion of the combination strategy that targets independent cellular pathways that can work synergistically is predicted. Here, we review some consequences of tumor cell death and increased immune system engagement in the modulation of oxidative stress and ubiquitin ligase pathways. We also indicate combinations of cancer immunotherapies and immunomodulatory targets. Additionally, we discuss imaging techniques, which are crucial for monitoring tumor responses during treatment and the immunotherapy side effects. Finally, the major outstanding questions are also presented, and directions for future research are described.
引用
收藏
页数:41
相关论文
共 50 条
  • [21] Targeting inflammasome/IL-1 pathways for cancer immunotherapy
    Guo, Beichu
    Fu, Shunjun
    Zhang, Jinyu
    Liu, Bei
    Li, Zihai
    SCIENTIFIC REPORTS, 2016, 6
  • [22] Targeting Metabolic Pathways of Myeloid Cells Improves Cancer Immunotherapy
    Li, Jianying
    Bolyard, Chelsea
    Xin, Gang
    Li, Zihai
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [23] Targeting inflammasome/IL-1 pathways for cancer immunotherapy
    Beichu Guo
    Shunjun Fu
    Jinyu Zhang
    Bei Liu
    Zihai Li
    Scientific Reports, 6
  • [24] Targeting key cellular signaling network for cancer chemotherapy and immunotherapy
    Chi, Hao
    Jiang, Lai
    Zhang, Shengke
    Liu, Yunfei
    Yang, Guanhu
    Tian, Gang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
    Ma, Shi-Xun
    Li, Li
    Cai, Hui
    Guo, Tian-Kang
    Zhang, Lei-Sheng
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (02): : 81 - 88
  • [26] Targeted immunotherapy of cancer: development of antibody-induced cellular immunity
    Lu, YJ
    Low, PS
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2003, 55 (02) : 163 - 167
  • [27] Cellular immunity and immunotherapy of brain tumors
    Prins, RM
    Liau, LM
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 3124 - 3136
  • [28] CELLULAR-IMMUNITY, ALLERGY AND IMMUNOTHERAPY
    PALMACARLOS, AG
    PALMACARLOS, ML
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1986, 2 (03): : 251 - 257
  • [29] Targeting cancer by binding iron: Dissecting cellular signaling pathways
    Lui, Goldie Y. L.
    Kovacevic, Zaklina
    Richardson, Vera
    Merlot, Angelica M.
    Kalinowski, Danuta S.
    Richardson, Des R.
    ONCOTARGET, 2015, 6 (22) : 18748 - 18779
  • [30] Special issue: Targeting cellular signaling pathways for cancer therapy
    Wang, Peter Zhiwei
    Wei, Wenyi
    SEMINARS IN CANCER BIOLOGY, 2022, 85 : 1 - 3